top of page

Study describes extraordinarily potent mRNA cancer immunotherapy

BioNTech AG has announced the publication of a study that describes the first example worldwide of a clinically relevant and systemic mRNA cancer immunotherapy.

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page